The laboratory conducts fundamental and applied research aimed at developing highly specific protein molecules for the diagnosis and treatment of oncological and infectious diseases. Key objectives include:

• Developing novel anti-tumor and virus-neutralizing antibodies, as well as engineering bispecific antibodies (BiTEs) and chimeric antigen receptors (CARs) based on these molecules for T-cell therapy;
• Developing three-dimensional organoid models of the intestine and lungs to study the molecular and cellular mechanisms of disease and to conduct preclinical evaluations of the efficacy and safety of therapeutic agents;
• Creating domestically produced reagents for organoid culture to expand the experimental infrastructure available for preclinical research.